Originally published on Wed February 29, 2012 3:36 pm
Scary labels the U.S. Food and Drug Administration would require on cigarette packages later this year were nixed today.
U.S. District Court Judge Richard Leon in Washington ruled the requirement that cigarette makers put the labels — some quite gruesome and all quite large — on their products would "violate the First Amendment by unconstitutionally compelling speech."
It has been a bit of a sour week for drinkers of raw milk.
Yesterday, the U.S. Food and Drug Administration said a federal court had granted it a permanent injunction to keep a Pennsylvania raw milk maker from distributing across state lines to raw milk buying clubs. The decision was the latest in an escalating battle between the federal government and producers and consumers of raw milk.
Since we introduced you to AeroShot, a product the delivers a blast of caffeine through an inhaler, a few months back, it seems a lot of folks — mostly around college campuses in New York and Boston — have tried the quick pick-me-up.
A key federal panel Wednesday recommended the Food and Drug Administration approve the first new weight-loss drug in more than a decade.
At the conclusion of a day-long hearing, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 20-2 to endorse a request from Vivus to approve the drug Qnexa. The same panel gave a thumbs-down to Qnexa in 2010.
Qnexa is a combination of two generic drugs that are already on the market: